Advertisement
Research Article| Volume 257, P160-167, April 15, 2018

Download started.

Ok

Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Nav1.5 gain-of-function mutation (G213D)

      Abstract

      Background: SCN5A mutations can lead to different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by ventricular ectopy and dilated cardiomyopathy.
      Methods & Results: A family with a uniform MEPPC-like phenotype, associated with complex atrial and ventricular arrhythmias and dilated cardiomyopathy caused by a high frequency of ventricular ectopy was clinically assessed. Screening of the SCN5A gene revealed a missense mutation in the linker between segments 3 and 4 in domain 1 of the Nav1.5 protein, resulting in a glycine to aspartate substitution at position 213 (G213D). The phenotype co-segregated with the missense mutation. Electrophysiological studies of wild type (WT) hNav1.5 and hNav1.5_G213D expressed in CHO-K cells showed that the voltage of half-maximal activation (V½) was significantly more negative for hNav1.5_G213D compared to WT (V½ = −38.7 ± 0.5 mV for WT and V½ = −42.4 ± 0.5 mV for G213D; P < 0.001). This suggests activation of Nav1.5_G231D at more negative potentials. The V½ of steady-state inactivation was significantly shifted towards more positive values for Nav1.5_G213D (V½ = −86.7 ± 0.2 mV for WT and −82.2 ± 0.3 mV for G213D; P < 0.001), also contributing to a gain-of-function phenotype. Flecainide and amiodarone markedly reduced premature atrial and ventricular contractions in four patients.
      Conclusion: The Nav1.5_G213D mutation is associated with a gain-of-function phenotype, multifocal atrial and ventricular ectopy and dilated cardiomyopathy. Since patients with a MEPPC-like phenotype may specifically benefit from Class-1 antiarrhythmic drugs or amiodarone, clinical identification of this disease entity is important.

      Abbreviations:

      AF (atrial fibrillation), DCM (dilated cardiomyopathy), ECG (electrocardiogram), EPS (electrophysiological study), LA (left atrium), LV (left ventricle), LVEF (left ventricular ejection fraction), MEPPC (multifocal ectopic Purkinje-related premature contractions), CMR (cardiac magnetic resonance imaging), MAT (multifocal atrial tachycardia), PAC (premature atrial contractions), PVC (premature ventricular contractions), (the half-maximal activation or inactivation voltage)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wilde A.A.M.
        • Brugada R.
        Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel.
        Circ. Res. 2011; 108: 884-897
        • Remme C.A.
        Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.
        J. Physiol. 2013; 591: 4099-4116
        • Nguyen T.P.
        • Wang D.W.
        • Rhodes T.H.
        • George A.L.
        Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia.
        Circ. Res. 2008; 102: 364-371
        • Remme C.A.
        • Wilde A.A.M.
        • Bezzina C.R.
        Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
        Trends in Cardiovascular Medicine. 2008; 18: 78-87
        • Laurent G.
        • Saal S.
        • Amarouch M.Y.
        • Béziau D.M.
        • Marsman R.F.J.
        • Faivre L.
        • et al.
        Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.
        J. Am. Coll. Cardiol. 2012; 60: 144-156
        • McNair W.P.
        • Sinagra G.
        • Taylor M.R.G.
        • Di Lenarda A.
        • Ferguson D.A.
        • Salcedo E.E.
        • et al.
        SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.
        J. Am. Coll. Cardiol. 2011; 57: 2160-2168
        • McNair W.P.
        • Ku L.
        • Taylor M.R.G.
        • Fain P.R.
        • Dao D.
        • Wolfel E.
        • et al.
        SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia.
        Circulation. 2004; 110: 2163-2167
        • Morales A.
        • Painter T.
        • Li R.
        • Siegfried J.D.
        • Li D.
        • Norton N.
        • et al.
        Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.
        Circulation. 2010; 121: 2176-2182
        • Nair K.
        • Pekhletski R.
        • Harris L.
        • Care M.
        • Morel C.
        • Farid T.
        • et al.
        Escape capture bigeminy: phenotypic marker of cardiac sodium channel voltage sensor mutation R222Q.
        Heart Rhythm. 2012; 9: 1681-1688.e1
        • Mann S.A.
        • Castro M.L.
        • Ohanian M.
        • Guo G.
        • Zodgekar P.
        • Sheu A.
        • et al.
        R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy.
        J. Am. Coll. Cardiol. 2012; 60: 1566-1573
        • Haas J.
        • Frese K.S.
        • Peil B.
        • Kloos W.
        • Keller A.
        • Nietsch R.
        • et al.
        Atlas of the clinical genetics of human dilated cardiomyopathy.
        Eur. Heart J. 2015; 36 (1123–35a. doi:10.1093/eurheartj/ehu301)
        • Hartmann H.A.
        • Tiedeman A.A.
        • Chen S.F.
        • Brown A.M.
        • Kirsch G.E.
        Effects of III-IV linker mutations on human heart Na+ channel inactivation gating.
        Circ. Res. 1994; 75: 114-122
        • Zhu Y.
        • Kyle J.W.
        • Lee P.J.
        Flecainide sensitivity of a Na channel long QT mutation shows an open-channel blocking mechanism for use-dependent block.
        Am. J. Physiol. Heart Circ. Physiol. 2006; 291: H29-37
        • Ghouse J.
        • Have C.T.
        • Weeke P.
        • Bille Nielsen J.
        • Ahlberg G.
        • Balslev-Harder M.
        • et al.
        Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval.
        Eur. Heart J. 2015; 36: 2523-2529
        • Baman T.S.
        • Lange D.C.
        • Ilg K.J.
        • Gupta S.K.
        • Liu T.-Y.
        • Alguire C.
        • et al.
        Relationship between burden of premature ventricular complexes and left ventricular function.
        Heart Rhythm. 2010; 7: 865-869
        • Niwano S.
        • Wakisaka Y.
        • Niwano H.
        • Fukaya H.
        • Kurokawa S.
        • Kiryu M.
        • et al.
        Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function.
        Heart. 2009; 95: 1230-1237
        • Bikkina M.
        • Larson M.G.
        • Levy D.
        Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study.
        Ann. Intern. Med. 1992; 117: 990-996
        • Dukes J.W.
        • Dewland T.A.
        • Vittinghoff E.
        • Mandyam M.C.
        • Heckbert S.R.
        • Siscovick D.S.
        • et al.
        Ventricular ectopy as a predictor of heart failure and death.
        J. Am. Coll. Cardiol. 2015; 66: 101-109
        • Olesen M.S.
        • Yuan L.
        • Liang B.
        • Holst A.G.
        • Nielsen N.
        • Nielsen J.B.
        • et al.
        High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation.
        Circ. Cardiovasc. Genet. 2012; 5: 450-459
        • Makiyama T.
        • Akao M.
        • Shizuta S.
        • Doi T.
        • Nishiyama K.
        • Oka Y.
        • et al.
        A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation.
        J. Am. Coll. Cardiol. 2008; 52: 1326-1334
        • Li Q.
        • Huang H.
        • Liu G.
        • Lam K.
        • Rutberg J.
        • Green M.S.
        • et al.
        Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing.
        Biochem. Biophys. Res. Commun. 2009; 380: 132-137
        • Wan E.
        • Abrams J.
        • Weinberg R.L.
        • Katchman A.N.
        • Bayne J.
        • Zakharov S.I.
        • et al.
        Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice.
        J. Clin. Invest. 2016; 126: 112-122
        • Catterall W.A.
        From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.
        Neuron. 2000; 26: 13-25
        • Chen-Izu Y.
        • Shaw R.M.
        • Pitt G.S.
        • Yarov-Yarovoy V.
        • Sack J.T.
        • Abriel H.
        • et al.
        Na+ channel function, regulation, structure, trafficking and sequestration.
        J. Physiol. 2015; 593: 1347-1360
        • Gui J.
        • Wang T.
        • Jones R.P.O.
        • Trump D.
        • Zimmer T.
        • Lei M.
        Multiple loss-of-function mechanisms contribute to SCN5A-related familial sick sinus syndrome.
        PLoS One. 2010; 5e10985
        • Gosselin-Badaroudine P.
        • Keller D.I.
        • Huang H.
        • Pouliot V.
        • Chatelier A.
        • Osswald S.
        • et al.
        A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype.
        PLoS One. 2012; 7e38331
        • Beckermann T.M.
        • McLeod K.
        • Murday V.
        • Potet F.
        • George A.L.
        Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.
        Heart Rhythm. 2014; 11: 1446-1453
        • Roden D.M.
        Pharmacology and toxicology of Nav1.5-class 1 anti-arrhythmic drugs.
        Card Electrophysiol Clin. 2014; 6: 695-704
        • Flecainide-Quinidine Research Group
        Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
        Circulation. 1983; 67: 1117-1123
        • Capucci A.
        • Di Pasquale G.
        • Boriani G.
        • Carini G.
        • Balducelli M.
        • Frabetti L.
        • et al.
        A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
        Int. J. Clin. Pharmacol. Res. 1991; 11: 23-33
        • Amarouch M.Y.
        • Swan H.
        • Leinonen J.
        • Marjamaa A.
        • Lahtinen A.M.
        • Kontula K.
        • et al.
        Antiarrhythmic action of flecainide in polymorphic ventricular arrhythmias caused by a gain-of-function mutation in the Nav 1.5 Sodium Channel.
        Ann. Noninvasive Electrocardiol. 2016; 21: 343-351
        • Remme C.A.
        • Wilde A.A.M.
        Targeting sodium channels in cardiac arrhythmia.
        Curr. Opin. Pharmacol. 2014; 15: 53-60

      Linked Article